An investigation on behalf of investors in Forte Biosciences, Inc. (NASDAQ:FBRX) shares over potential wrongdoing at Forte Biosciences, Inc. was announced.
San Diego, CA -- (SBWIRE) -- 10/27/2021 -- An investigation was announced over potential breaches of fiduciary duties by certain directors at Forte Biosciences, Inc.
Investors who purchased shares of Forte Biosciences, Inc. (NASDAQ: FBRX) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Forte Biosciences directors breached their fiduciary duties and caused damage to the company and its shareholders.
Torrance, CA based Forte Biosciences Inc. operates as a clinical-stage biopharmaceutical company in the United States. Forte Biosciences, Inc. reported that its annual Total Revenue rose from $4.06 million in 2019 to $14.25 million in 202, and that its Net Loss increased from $4.064 million in 2019 to $46.48 million in 2020
On September 2, 2021, post-market, Forte Biosciences, Inc. issued a press release "announc[ing] that topline data from its Phase 2 clinical trial of FB-401 for the treatment of atopic dermatitis failed to meet statistical significance for the primary endpoint of EASI-50 (the proportion of patients with at least a 50% improvement in atopic dermatitis disease severity as measure by EASI)."
Shares of Forte Biosciences, Inc. (NASDAQ: FBRX) declined from $31.47 per share on September 2, 2021, to $4.06 per share on September 7, 2021.
Those who purchased shares of Forte Biosciences, Inc. (NASDAQ: FBRX) have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.